Vital NETosis vs. suicidal NETosis during normal pregnancy and preeclampsia.

Florence Guillotin, Mathieu Fortier, Marie Portes, Christophe Demattei, Eve Mousty, Eva Nouvellon, Eric Mercier, Mathias Chea, Vincent Letouzey, Jean-Christophe Gris, Sylvie Bouvier
Author Information
  1. Florence Guillotin: Department of Haematology, University Hospital, Nîmes, France.
  2. Mathieu Fortier: Department of Haematology, University Hospital, Nîmes, France.
  3. Marie Portes: Department of Gynecology and Obstetrics, University Hospital, Nîmes, France.
  4. Christophe Demattei: Department of Biostatistics, Public Health and Innovation in Methodology, Nîmes University Hospital, Nîmes, France.
  5. Eve Mousty: Department of Gynecology and Obstetrics, University Hospital, Nîmes, France.
  6. Eva Nouvellon: Department of Haematology, University Hospital, Nîmes, France.
  7. Eric Mercier: Department of Haematology, University Hospital, Nîmes, France.
  8. Mathias Chea: Department of Haematology, University Hospital, Nîmes, France.
  9. Vincent Letouzey: Department of Gynecology and Obstetrics, University Hospital, Nîmes, France.
  10. Jean-Christophe Gris: Department of Haematology, University Hospital, Nîmes, France.
  11. Sylvie Bouvier: Department of Haematology, University Hospital, Nîmes, France.

Abstract

NETosis occurs in the context of infection or inflammation and results in the expulsion of decondensed DNA filaments called NETs (Neutrophil Extracellular Traps) into the extracellular environment. NETosis activates coagulation and contributes to the thrombotic risk of inflammatory diseases. To date, two mechanisms of NETosis have been identified: suicidal NETosis, in which neutrophils die after expelling the filaments; and vital NETosis, in which expulsion appears without altering the membrane. Human pregnancy is associated with a mild pro-inflammatory state, which is increased in the event of complications such as preeclampsia (PE). NETosis has been observed in these situations, but the mechanism of its production has not yet been studied. The aim of our study was to evaluate the balance of vital vs. suicidal NETosis in normal pregnancy and in PE. Neutrophils from healthy volunteers were stimulated with plasma from normal pregnancies (n = 13) and from women developing preeclampsia (n = 13). Immunofluorescent labelling was performed to determine the percentages and origin of NETs in both groups. Inhibition with suicidal or vital NETosis inhibitors was also performed to validate our results. We found a significant increase in NETs in women with PE compared to women with normal pregnancies. We showed that vital and non-vital NETosis are present in normal and preeclamptic pregnancies. We demonstrated that the higher proportion of NETs observed in PE was due to non-vital NETosis whose main component is represented by suicidal NETosis. These results suggest the important part of non-vital NETosis in the pathophysiology of PE.

Keywords

References

  1. Cell Microbiol. 2006 Apr;8(4):668-76 [PMID: 16548892]
  2. Acta Pharmacol Sin. 2021 Jun;42(6):954-963 [PMID: 32968210]
  3. Science. 2004 Mar 5;303(5663):1532-5 [PMID: 15001782]
  4. J Innate Immun. 2014;6(6):765-79 [PMID: 24862346]
  5. Hypertension. 2018 Jul;72(1):24-43 [PMID: 29899139]
  6. J Cell Biol. 2007 Jan 15;176(2):231-41 [PMID: 17210947]
  7. Front Immunol. 2012 Nov 27;3:362 [PMID: 23205021]
  8. Blood. 2011 Aug 18;118(7):1952-61 [PMID: 21673343]
  9. Hypertension. 2022 Mar;79(3):536-548 [PMID: 34984912]
  10. Semin Immunopathol. 2007 Jun;29(2):163-7 [PMID: 17621701]
  11. Immunology. 2015 Jun;145(2):213-24 [PMID: 25545227]
  12. Cold Spring Harb Perspect Biol. 2020 Jul 1;12(7): [PMID: 31767647]
  13. PLoS Pathog. 2009 Oct;5(10):e1000639 [PMID: 19876394]
  14. Hum Immunol. 2005 Nov;66(11):1146-54 [PMID: 16571415]
  15. Thromb Haemost. 2018 Dec;118(12):2064-2073 [PMID: 30453347]
  16. Biol Reprod. 2016 Dec;95(6):132 [PMID: 28007693]
  17. PLoS One. 2013 Sep 20;8(9):e75141 [PMID: 24073241]
  18. Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2817-22 [PMID: 25730848]
  19. Blood. 2011 Jan 20;117(3):953-9 [PMID: 20974672]
  20. Clin Exp Immunol. 2019 Oct;198(1):24-36 [PMID: 30768780]
  21. Ann N Y Acad Sci. 2006 Sep;1075:118-22 [PMID: 17108200]
  22. J Immunol. 2010 Dec 15;185(12):7413-25 [PMID: 21098229]
  23. J Cell Biol. 2010 Nov 1;191(3):677-91 [PMID: 20974816]
  24. Clin Chem. 2005 Sep;51(9):1577-86 [PMID: 16020501]
  25. Cell Rep. 2014 Aug 7;8(3):883-96 [PMID: 25066128]
  26. Blood. 2013 Oct 17;122(16):2784-94 [PMID: 24009232]
  27. Obstet Gynecol. 2019 Jan;133(1):1 [PMID: 30575675]
  28. Biochem Soc Trans. 2015 Aug;43(4):696-701 [PMID: 26551715]
  29. Biochem J. 1993 Feb 15;290 ( Pt 1):41-9 [PMID: 8439298]
  30. Fetal Diagn Ther. 2016;40(4):263-267 [PMID: 26998969]
  31. Pathogens. 2021 Jan 24;10(2): [PMID: 33498871]
  32. J Thromb Haemost. 2020 Dec;18(12):3371-3380 [PMID: 32979032]
  33. Scand J Immunol. 2018 Apr;87(4):e12651 [PMID: 29479732]
  34. Front Pharmacol. 2021 Apr 26;12:657486 [PMID: 33981234]
  35. Cancer Immunol Immunother. 2020 Feb;69(2):199-213 [PMID: 31982939]
  36. Nat Med. 2012 Sep;18(9):1386-93 [PMID: 22922410]
  37. Front Immunol. 2018 Jan 09;8:1849 [PMID: 29375550]
  38. Front Immunol. 2016 Dec 05;7:565 [PMID: 27994595]
  39. Front Immunol. 2016 Nov 04;7:484 [PMID: 27867387]
  40. J Cell Biol. 2009 Jan 26;184(2):205-13 [PMID: 19153223]
  41. Nat Med. 2007 Apr;13(4):463-9 [PMID: 17384648]
  42. Thromb Haemost. 2021 Jul;121(7):877-890 [PMID: 33423243]
  43. J Immunol. 2018 Jan 15;200(2):869-879 [PMID: 29196457]

Word Cloud

Created with Highcharts 10.0.0NETosissuicidalvitalPEnormalNETspregnancypreeclampsiaresultspregnancieswomennon-vitalexpulsionfilamentsobservedvsn=13performedoccurscontextinfectioninflammationdecondensedDNAcalledNeutrophilExtracellularTrapsextracellularenvironmentactivatescoagulationcontributesthromboticriskinflammatorydiseasesdatetwomechanismsidentified:neutrophilsdieexpellingappearswithoutalteringmembraneHumanassociatedmildpro-inflammatorystateincreasedeventcomplicationssituationsmechanismproductionyetstudiedaimstudyevaluatebalanceNeutrophilshealthyvolunteersstimulatedplasmadevelopingImmunofluorescentlabellingdeterminepercentagesorigingroupsInhibitioninhibitorsalsovalidatefoundsignificantincreasecomparedshowedpresentpreeclampticdemonstratedhigherproportionduewhosemaincomponentrepresentedsuggestimportantpartpathophysiologyVitalneutrophil

Similar Articles

Cited By (7)